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Evaluation of Mutagenicity Testing with
Salmonella typhimuriumTAIO2 in Three
Different Laboratories
by W. MuIIer,'G. Engelhart,' B. Herbold, R. Jackh, and
R. Jung,1
Thirty compounds ofvarious chemical classes were investigated for mutagenicity in a collaborative study
(three laboratories) using Salmonella typhimurium TA102. With five compounds, hydrazine sulfate, phenyl-
hydrazine, hydralazine, glutardialdehyde, and glyoxal, mutagenicity was detected by all laboratories. Formal-
dehyde was assessed as weakly mutagenic in only one of three laboratories. The remaining 24 agents were
uniformly described as nongenotoxic in TA102. In spite of the overall good qualitative agreement in the
mutagenicity results between the three laboratories, some quantitive discrepancies occurred in the dose
response ofthe mutagenic compounds. Varying inter- and intralaboratory differences in the spontaneous rate
of revertants were obtained. The usefulness of the tester strain TA102 in routine mutagenicity testing is
discussed.
Introduction
The development of the new tester strain Salmonella
typhimurTium TA102 prompted consideration ofusingthis
bacterial strain on a routine basis in the Ames test (1,2).
The tester strain has a different specificity from other
Salmonella strains routinely used in mutagenicity screen-
ing. It detects a variety ofoxidative mutagens and seems
to be more sensitive to some aldehydes (3) and some DNA-
damaging compounds, which are negative with other Sal-
monella strains (2).
Amechanism otherthangenotoxicity canmimic amuta-
genic response in TA102, leading to false positive results
due to an increase in pAQ1 plasmids in the cell (4). A
doubling of the spontaneous mutation rate per plate
occurred after pretreatment with high levels of
tetracycline (3). According to the authors, this effect was
presumably caused by an increased copy number of the
pAQ1 plasmid (3). About 30 copies ofthe mutant gene are
available in TA102. According to the literature, the spon-
taneous frequency ofrevertants inTA102 is about240-320
revertants per plate.
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This collaborative study was perfomed in three labora-
tories. Thirtycompounds ofvarious chemical classeswere
selected to determine the usefulness of the strain TA102
for screening purposes in mutagenicity testing. Ten com-
pounds were used because they had been tested in a
battery ofshort-term tests in another collaborative study
ofshort-termtestsforcarcinogenspublished in1985(5)by
WHO (World Health Organization), IPCS (International
Programme on Chemical Safety): hexamethylphosphora-
mide (HMPA), o-toluidine, safrol, diethylstilbestrol (DES),
benzene, acrylonitrile, diethylhexylphthalate (DEHP),
and phenobarbital. These compounds were evaluated as
carcinogens being essentially nonmutagenic for Salmo-
nellawithaweakresponseinTA102onlywithacrylonitrile
(6). Two noncarcinogens used in the WHO study, caprolac-
tam and benzoin, where detailed cancer bioassays in rats
and mice are available, served as presumptive negative
controls. Acryliamide was selected as a compound that is
not mutagenic in standard Ames tests but is known for
clastogenic in vivo (7,8).
Several aldehydes and aldehydeprecursorswereincluded
in the study: formaldehyde, acroleine, glyoxal, glutardial-
dehyde, anisaldehyde, vinylacetate, and methylvinyl-
ketone as a 13-unsaturated (acroleine analogue) ketone,
whichrecentlyhasbeendescribed as amutageninSalmo-
nella typhimurium strain TA100 (9). HMPAis apowerful
nasal carcinogen viewed as a compound with genotoxic
potential by releasing formaldehyde within nasal cells.MULLER ETAL.
Hydrazine and hydroxylamine were reported earlier as
mutagenic in TA102 (10) but not in other tester strains.
Therefore, these compounds and the hydrazine deriva-
tives, hydralazine and phenylhydrazine, were included in
the study to investigate the usefulness ofTA102 to detect
the genotoxic potential ofthese compounds.
Aromatic amines oftenproducepoorresultsinstandard
Amestests. Therefore, aniline was selcted and in addition,
m- and p-toluidine due to their structural similarly to
o-toluidineusedintheWHO/IPCDstudy.Butanol,though
apotential precursor ofbutyric aldehyde, was selected as
likelytobenegative; 2-aminoanthracene andmitomycin C
served as positive controls.
Thecompoundswerejudgedasmutagenicifareproduc-
ible, dose dependent increase in the number ofrevertants
was observed. This increase had to be about twice the
spontaneous rate or at least200 colonies overbackground
to meet the criterion for mutagenicity. In the few cases
where the increase was between 100 and 200 pug/plate
above background, this effect was judged as weak effect
(w+). Statistical analysis of the data was not made
because no appropriate statistics are suggested in the
original papers (5).
Material and Methods
Allchemicalsusedfortestingwere ofthehighestpurity
available. The chemical sources and CAS numbers are as
listed in Table 1.
The phenotypically characterized tester strain TA102
was obtained from B.N. Ames (University of California,
Chemical
Acrolein
Acrylamide
Acrylonitrile
Aniline
Anisaldehyde
Benzene
Benzoin
Butylalcohol
Caprolactam
Diethylhexylphthalate
Diethylstilbestrol
DMPU
Formaldehyde
Glutardialdehyde
Glyoxal
HMPA
Hydralazine-HCl
Hydrazinsulfate
Hydroxylamin
Isoniacid
Limonen
Methylethylketon
Methylvinylketon
Phenobarbital
Phenylhydrazine
Safrol
m-Toluidine
o-Toluidine
p-Ibluidine
Vinylacetate
[lable 1. Chemicals tested.
CAS No.
107-02-8
79-06-1
107-13-1
62-53-3
123-11-5
71-43-3
119-53-9
71-36-3
105-60-2
117-81-7
56-53-1
7226-23-5
50-00-0
11 1-30-8
107-22-2
680-31-9
304-20-1
10034-93-2
5470-1 1-1
54-85-3
5989-27-5
78-93-3
78-94-4
57-30-7
100-63-0
94-59-7
108-44-1
95-53-4
106-49-0
108-05-4
Supplier
Merck
Merck
Merck
Merck
Merck
Merck
Merck
Aldrich
Merck
Merck
Sigma
Merck
Merck
Merck
Merck
Sigma
Aldrich
Aldrich
Sigrna
Merck
Fluka
Merck
Merck
Merck
Merck
Merck
Merck
Merck
Merck
Merck
Berkeley, CA). The original strainwas sent directlyto the
three collaborating laboratories. All experiments were
done from the original stock culture (without further
subculture). No further safeguard checks of phenotype
consistencies were made.
The compounds were tested formutagenicityusingthe
procedure of the Salmonella/mammalian-microsome
mutagenicity test as described (1) and as specified for
TA102 (3). Bacteria were grown in nutrient broth, and
aliquots were frozen at -80°C. All experiments were
performed from the same frozen batch except where
stated otherwise. For metabolic activation, a 10% S9 mix
from livers ofAroclor-1254-induced Sprague-Dawley rats
was used.
All compounds were tested in at least two independent
experiments using five doses and three plates per dose.
The solvents used for diluting the test compounds were
water, ethanol, or dimethyl sulfoxide. All compounds were
originally tested up to 5000 ,ug per plate whenever
possible. Limitations were given by cytotoxicity or pre-
cipitation.
Results and Discussion
The results obtained independently in three laborato-
ries are summarized in Table 2. Sixof30 chemicals tested
Table 2, Mutagenicity results of30 compounds with
TA102 in 3 independent laboratories.a
Resultsb
Compound Lab 1 Lab 2 Lab 3
Acrolein - (W) - (W) - (E)
Acrylamide - (W) - (W) - (W)
Acrylnitrile - (W) - (E) - (E)
Anilin - (E) - (E) - (E)
Anisaldehyde - (D) - (E) - (E)
Benzene - (D) - (W) - (D)
Benzoin - (D) - (D) - (D)
Butanol - (W) - (E) - (W)
Caprolactam - (W) - (W) - (W)
Diethylhexylphthalate - (D) - (E) - (D)
Diethylstilbestrol - (D) - (E) - (D)
DMPU - (W) - (W) - (D)
Formaldehyde W+(W) - (W) - (W)
Glutardialdehyde +(W) +(W) W+(E)
Glyoxal +(W) +(W) +(W)
HMPA - (W) - (V) - (D)
Hydralazine-HCl +(D) +(W) +(W)
Hydrazin-sulfate +(D/W) +(W) +(W)
Hydroxylamine - (W) - (W) - (W)
Isoniacid - (W) - (W) - (W)
Limonen -(D/E) - (E) - (D)
Methylethylketon - (W) - (W) - (E)
Methylvinylketon - (W) - (E) - (E)
Phenobarbital - (W) - (W) - (W)
Phenylhydrazine +(W) +(W) +(D)
Safrol - (E) - (E) - (D)
m-Toluidine - (D) - (E) - (E)
o-Toluidine -(D/E) - (E) - (E)
p-Toluidine -(D/E) - (E) - (W)
Vinylacetate - (E) - (E) - (E)
aSolvent used in parentheses: (W) water, (E) ethanol, (D)
dimethylsulfoxide.
b-,Notmutagenic; +,mutagenic(> 2-foldof<200colonies/plate over
control); W+, weak effect (100-200 colonies/plate over control).
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FIGURE 1. Mutagenicityofhydralazin-HCl inSalmonellatyphimurium
strain TA102 with S9 mix in Lab 1..- *), Lab 2(---), Lab 3 (-).
Phenylhydrazine
700
600 r
300
200 .
0 500 1000
micro-g/plate
FIGURE 2. Mutagenicity of phenylhydrazine in Salmonella typhi-
muriumstrainTA109with S9mixin Lab 1 (..* ), Lab2(----), Lab3(-).
FIGURE 4. Mutagenicity of glutardialdehyde in Salmonella
typhimurium strainTA102with S9 mixin Lab 1(... ), Lab2(- --), Lab3
(-)
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Figure 5. Mutagenicity of hydrazine sulfate and in Salmonella
typhimurium strain TA102with S9 mixin Lab 1(... *), Lab2 (- --), Lab3
(-).
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FIGURE 3. Mutagenicity ofglyoxal in Salmonella typhimurium strain
in TA102 with S9 mix in Lab 1 (*. ), Lab 2 (- - -), Lab 3 (-).
showedmutagenicactivity. Hydralazine,.phenylhydrazine,
and glyoxal were described uniformly as mutagenic in all
three laboratories. The dose-response curves for these
three compounds are given in Figures 1-3.
Inallcasesmutagenicityofthecompoundswasequalor
more pronounced in the presence of liver S9 mix. The
maximum response with hydralazine-HCl revealed a sig-
nificant difference in the number of revertants between
the three laboratories at the dose level of 2400 ,ug/plate
(laboratory1) and2500 ,ug/plate (laboratories 2 and3; Fig.
1). The highest increase in revertants was reported in all
three cases at this dose. However, in laboratory 1 the
induced mutation frequency was more than twice as high
as in laboratory 2 (2.7-fold) and laboratory 3 (2.1-fold).
Higher doses (>2500 jig/plate)were notrelevantfortest-
ing due to cytotoxicity.
Comparison of the dose-response curve with phenyl-
hydrazine revealed some quantitative differences interms
of maximum revertants per plate (Fig. 2). The induced
mutationfrequencies, however,werenotalwaysconsistent
in quantitative terms. In particular, at the top dose levels
(1000 ,ug/plate), quantitative differenceswereobvious. The
quantitative differences in the absolute numbers ofrever-
tantswere minimizedwhenreferred tothe corresponding
control values. In comparison to published data (3), the
mutation rate for all the three laboratories was smaller in
spite ofsimilar control values.
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The coincidence ofdatawithglyoxalwas satisfactoryup
to 2500 ,ug/plate for all laboratories (Fig. 3). Differences
occurred mainly at 5000 ,ug/plate,where onlylaboratories
1 and 3 could detectafurtherincrease ofmutagenicity. As
inthe case ofphenylhydrazine, theresults oftheselabora-
tories showed a lower mutagenicity response (3).
Glutardialdehyde and hydrazine sulfatewerejudged as
mutagenic in laboratory 1 and 2, whereas only aweakbut
reproducible increase in the number of revertants was
detectedinlaboratory3 (Figs. 4,5).Withglutardialdehyde
and hydrazinesulfate, laboratory 1 reported the highest
effect on the induced numbers ofmutation and the muta-
tionfrequency.Thedose-effectincreasewasmuchsteeper
in the experiments oflaboratory 1 than those oflaborato-
ries 2 and 3.
Formaldehyde, which has been described as mutagenic
(2,3), was evaluated as a weak mutagenic compound with
andwithoutmetabolic activationinoneoftheparticipating
laboratories only. However, even laboratory 1 had difficul-
ties obtaining amutagenicity response in the first experi-
ments. The TA102 strain in this laboratory initially had
also given negative responses when several different
batches of formaldehyde were investigated. Only after
testingthe compound with a new sample ofTA102 (kindly
provided by B. Ames) was mutagenicity demonstrated.
In total, the results ofour study are in line with recent
findings (11). We were unable to achieve the high induced
revertantcountswithseveralcompounds (3). Inparticular,
with formaldehyde the maximum-fold increase in TA100
was reported to be only 50% over the control value.
Analysis of the negative controls of all experiments
demonstrates relevant variation (Table 2). The spon-
taneous rate was generally lower in laboratories 1 and 2
than in laboratory 3. Mean control values of all experi-
ments were also lower in laboratories 1 and 2 than in
laboratory 3. Comparison ofthe induced mutations gener-
ally reveals the smaller effects in laboratory 3. This may
partly be correlated to higher negative control values in
this laboratory.
Summary
In summary, there was general agreement in terms of
qualitativetestresults; somequantitative differenceswere
obvious among the results of the three laboratories. The
differences in the spontaneous rate of revertants my
reflect varying plasmid copies in the bacterial cells.
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